economy
March 11, 2026
Jim Cramer says Eli Lilly has checked the most important box as obesity pill approval looms
The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET.
TL;DR
- S&P 500 drifted lower due to inflation data, U.S.-Iran war, and oil prices, but the market is focused on future CPI prints.
- International Energy Agency plans to release oil reserves, but prices still rose; stock market entered oversold territory, leading to buying opportunities like Procter & Gamble.
- CrowdStrike shares are seen as undervalued given the growing discussion around AI agents and security breaches.
- Eli Lilly's GLP-1 pill, orforglipron, has a massive opportunity, and the company is prepared for production, unlike some competitors.
- Stocks discussed in rapid fire: Campbell's, Cintas, CarMax, and J.M. Smucker.
Continue reading the original article